The five-year plan will join up some of the country’s best universities, leading innovators and local authorities to solve some of the biggest issues facing health and social care.
News
NICE recommends gammaCore for cluster headaches
The portable technology aims to modify pain signals by stimulating the vagus nerve through the skin of the neck.
HPV vaccine to be offered to school-age boys
Girls have been offered the jab free from the NHS since 2008.
NHS improvements can’t happen ‘overnight’, says NHS Confederation
The King’s Fund Quarterly Monitoring Report suggested that patients face a long wait before they will see improvements in care as a result of the government’s £20 billion NHS funding boost.
GSK’s Dovato hits endpoints in late-stage study
In a Phase III study the drug combo was as effective in controlling HIV-1 as a Vemlidy combo.
Amazon’s Alexa to offer NHS healthcare advice
Amazon’s algorithm will use information from the NHS website to provide the answers.
Pharma industry invests £377m in UK R&D collabs
ABPI chief said that the investment from companies is “excellent news at a time of economic uncertainty and signals the strength of the sector in the UK.”
Healthcare regulators to gain autonomy
The new release outlines how the regulation of healthcare workers will better support professionals and modern fitness to practise processes.
An exciting new opportunity & reward for finalists of the 2019 Sales Awards
PharmaTimes have partnered with the Applied Healthcare Academy for the 2019 Sales Awards to give entrants and winners an added bonus for their success.
Roche presents positive late-stage Hemlibra data
Haemophilia A is an inherited, serious disorder in which a person’s blood does not clot properly.
AMR pushes NHS to trial ‘subscription-style’ payment model
Companies are set to be paid based on the value the medicine brings to the NHS.
Xarelto success in paediatric venous thromboembolism
The full findings of the study were presented during a late-breaking session at the 27th Congress of the International Society on Thrombosis and Haemostasis.
NICE Onpattro approval puts Alnylam back in hATTR running
NICE issued the drug a preliminary ‘no’, back in December 2018.
Darzalex, Ibrance among latest SMC decisions
The Scottish Medicines Consortium (SMC) has announced its latest round of decisions for NHS Scotland, publishing advice accepting three new medicines.
Options available for individual entry in the 2019 Communications Team of the Year competition
There are options available for individual entry in the 2019 PharmaTimes Communications Team of the Year competition, alongside the prestigious team challenges.
